FI66001C - Foerfarande foer framstaellning av 3-aminoetyltio-6-(1-hydroxietyl)-1-azabicyklo(3.2.0)hept-2-en-7-on-2-karboxylsyra och dess farmaceutiskt godtagbara salter och estrar - Google Patents

Foerfarande foer framstaellning av 3-aminoetyltio-6-(1-hydroxietyl)-1-azabicyklo(3.2.0)hept-2-en-7-on-2-karboxylsyra och dess farmaceutiskt godtagbara salter och estrar Download PDF

Info

Publication number
FI66001C
FI66001C FI791378A FI791378A FI66001C FI 66001 C FI66001 C FI 66001C FI 791378 A FI791378 A FI 791378A FI 791378 A FI791378 A FI 791378A FI 66001 C FI66001 C FI 66001C
Authority
FI
Finland
Prior art keywords
tai
mmol
formula
tert
solution
Prior art date
Application number
FI791378A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI791378A (fi
FI66001B (fi
Inventor
Burton Grant Christensen
Ronald William Ratcliffe
Thomas Norse Salzmann
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25463739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI66001(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to FI792497A priority Critical patent/FI75803C/fi
Publication of FI791378A publication Critical patent/FI791378A/fi
Priority to FI832898A priority patent/FI78071C/fi
Application granted granted Critical
Publication of FI66001B publication Critical patent/FI66001B/fi
Publication of FI66001C publication Critical patent/FI66001C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI791378A 1978-08-14 1979-04-27 Foerfarande foer framstaellning av 3-aminoetyltio-6-(1-hydroxietyl)-1-azabicyklo(3.2.0)hept-2-en-7-on-2-karboxylsyra och dess farmaceutiskt godtagbara salter och estrar FI66001C (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI792497A FI75803C (fi) 1978-08-14 1979-08-10 Vid framstaellning av tienamycin och homotienamycin saosom mellanprodukt anvaendbar 4-jodmetylazetidin-2-on och foerfarande foer dess framstaellning.
FI832898A FI78071C (fi) 1978-08-14 1983-08-11 Mellanprodukt anvaendbar vid framstaellning av tienamycin.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/933,323 US4174316A (en) 1978-08-14 1978-08-14 4-Iodomethylazetidin-2-one
US93332378 1978-08-14

Publications (3)

Publication Number Publication Date
FI791378A FI791378A (fi) 1980-02-15
FI66001B FI66001B (fi) 1984-04-30
FI66001C true FI66001C (fi) 1984-08-10

Family

ID=25463739

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791378A FI66001C (fi) 1978-08-14 1979-04-27 Foerfarande foer framstaellning av 3-aminoetyltio-6-(1-hydroxietyl)-1-azabicyklo(3.2.0)hept-2-en-7-on-2-karboxylsyra och dess farmaceutiskt godtagbara salter och estrar

Country Status (8)

Country Link
US (1) US4174316A (es)
EP (1) EP0007973B1 (es)
JP (4) JPS5527169A (es)
DE (1) DE2966598D1 (es)
DK (1) DK169971B1 (es)
ES (2) ES480127A1 (es)
FI (1) FI66001C (es)
IE (1) IE48728B1 (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275207A (en) * 1978-08-14 1981-06-23 Merck & Co., Inc. Process for preparing 7-(1-hydroxyethyl)-3-(2-aminoethylthio)-1-carbadethiaceph-3-em-3-carboxylic acid and intermediate therefor
JPS55147284A (en) * 1979-04-17 1980-11-17 Sanraku Inc Novel beta-lactam derivative and its preparation
DE3071008D1 (en) * 1979-04-27 1985-09-26 Merck & Co Inc Process for the preparation of 3-(1-hydroxyethyl)-azetidinones
PT71553B (en) * 1979-07-23 1981-12-14 Merck & Co Inc Process for the preparation of thienamycin and intermediates
PT71552B (en) * 1979-07-23 1981-12-14 Merck & Co Inc Process for preparation of thienamycin and intermediates
US4400323A (en) * 1979-07-23 1983-08-23 Merck & Co., Inc. 3-[1-Hydroxyethyl]-4-carboxymethyl-azetidin-2-one
EP0028151A1 (en) * 1979-10-29 1981-05-06 Beecham Group Plc Process for the preparation of antibiotics
GR72296B (es) * 1979-12-03 1983-10-18 Merck & Co Inc
US4262010A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids
DE3167774D1 (en) * 1980-02-28 1985-01-31 Fujisawa Pharmaceutical Co 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics
US4309346A (en) * 1980-03-27 1982-01-05 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
DE3169321D1 (en) * 1980-03-27 1985-04-25 Merck & Co Inc Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
JPS56154484A (en) * 1980-05-01 1981-11-30 Merck & Co Inc 1-carbapenems derived from-4azetidinone and manufacture of intermediate therefor
JPS5777670A (en) * 1980-10-31 1982-05-15 Microbial Chem Res Found Preparation of 2-azetidinone derivative
JPS57123182A (en) * 1980-12-18 1982-07-31 Merck & Co Inc 6- and 4-substituted-1-azabicyclo(3,1,2,0)heptane- 3,7-dione-2-carboxylate
US4348325A (en) * 1981-03-30 1982-09-07 Merck & Co., Inc. Methyl 3-azido-4-C-cyano-2,3,4,6-tetradeoxy-α-D-arabino-hexopyranoside
EP0073451B1 (en) * 1981-08-27 1987-05-13 Fujisawa Pharmaceutical Co., Ltd. Carbapenam compound and processes for the preparation thereof
WO1983002614A1 (en) * 1982-02-02 1983-08-04 Takeda Chemical Industries Ltd 5,6-cis-carbapenem-3-carboxylic acid derivatives and process for their preparation
JPS5865291A (ja) * 1981-10-14 1983-04-18 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体およびその製法
CA1190236A (en) * 1981-10-23 1985-07-09 Edward J.J. Grabowski Antibiotic synthesis
JPS58103391A (ja) * 1981-12-11 1983-06-20 Meiji Seika Kaisha Ltd １−オキサデチア−セフエム誘導体の製造法
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
US4472576A (en) * 1982-12-03 1984-09-18 Merck & Co., Inc. Processes for the production of antibiotic 1-oxadethiacephalosporins
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
CA1220215A (en) * 1983-03-07 1987-04-07 Yasutsugu Ueda Carbapenem intermediates
EP0133670A3 (de) * 1983-08-09 1985-12-18 Bayer Ag Verfahren zur Herstellung von 7-Acylamino-3-hydrocy-cephem-4-carbonsäuren und 7-Acylamino-3-hydroxy-1-de-thia-1-oxacephem-4-carbonsäuren
JPS60260580A (ja) * 1985-04-05 1985-12-23 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体およびその製造法
US4665171A (en) * 1985-07-17 1987-05-12 Harvard University Process and intermediates for β-lactam antibiotics
US4782051A (en) * 1985-06-10 1988-11-01 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3 carboxylic acids
US4783453A (en) * 1985-06-10 1988-11-08 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids
US4892869A (en) * 1985-06-10 1990-01-09 Merck & Co., Inc. 2-aza substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4833167A (en) * 1985-06-10 1989-05-23 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids
US4751296A (en) * 1986-08-06 1988-06-14 University Of Notre Dame Du Lac Process for 4-halomethyl-azetidinones by cyclization of O-acylhydroxamates
JPS6354359A (ja) * 1987-03-05 1988-03-08 Sankyo Co Ltd ４―カルボキシメチルアゼチジノン誘導体の製法
JPS6345250A (ja) * 1987-03-05 1988-02-26 Sankyo Co Ltd β−ラクタム化合物
JP2503247B2 (ja) * 1988-04-01 1996-06-05 三共株式会社 アゼチジノン誘導体
US5051502A (en) * 1990-06-06 1991-09-24 University Of Notre Dame Du Lac Rhodium catalyzed cyclization process for bicyclic β-lactams
US5189158A (en) * 1991-03-20 1993-02-23 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
EP0937725A3 (en) 1992-04-28 2004-12-01 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for hydroxy group
US5587474A (en) * 1992-06-18 1996-12-24 Tanabe Seiyaku Co., Ltd. Method for removing the protecting group for carboxyl group
WO2006121708A1 (en) * 2005-05-06 2006-11-16 Allergan, Inc. Substituted beta-lactams and their use in medicine
US8202855B2 (en) 2008-03-04 2012-06-19 Allergan, Inc Substituted beta-lactams

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122086A (en) * 1977-07-26 1978-10-24 Smithkline Corporation Isopenicillins
JPS55147284A (en) * 1979-04-17 1980-11-17 Sanraku Inc Novel beta-lactam derivative and its preparation

Also Published As

Publication number Publication date
ES8104295A1 (es) 1981-04-16
JPH03184979A (ja) 1991-08-12
JPH03184954A (ja) 1991-08-12
JPS6479182A (en) 1989-03-24
ES480127A1 (es) 1980-09-01
JPH0353313B2 (es) 1991-08-14
EP0007973A1 (en) 1980-02-20
IE48728B1 (en) 1985-05-01
EP0007973B1 (en) 1984-02-01
FI791378A (fi) 1980-02-15
DK169971B1 (da) 1995-04-18
JPS5527169A (en) 1980-02-27
JPH05384B2 (es) 1993-01-05
FI66001B (fi) 1984-04-30
IE790374L (en) 1980-02-14
JPH0248556B2 (es) 1990-10-25
JPH0780884B2 (ja) 1995-08-30
ES492056A0 (es) 1981-04-16
US4174316A (en) 1979-11-13
DK178979A (da) 1980-02-15
DE2966598D1 (en) 1984-03-08

Similar Documents

Publication Publication Date Title
FI66001C (fi) Foerfarande foer framstaellning av 3-aminoetyltio-6-(1-hydroxietyl)-1-azabicyklo(3.2.0)hept-2-en-7-on-2-karboxylsyra och dess farmaceutiskt godtagbara salter och estrar
EP0071908B1 (en) 1-, and 1,1-disubstituted-6-substituted-2-carbamimidoyl-1-carbadethiapen-2-em-3-carboxylic acids, a process for preparing and an antibiotic composition containing the same
CN100422184C (zh) 美罗培南的制备方法
EP0037081A1 (en) Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates
EP0037080B1 (en) 4-(3-carboxy-2-oxopropyl)-azetidino-2-ones and process for their preparation
US4290947A (en) Process for the preparation of thienamycin and intermediates
EP0001627A1 (en) 3-Substituted-6-(1'hydroxethyl)-7-oxo-1-azabicyclo(3.2.0.)-hept-2-ene-2-carboxylic acid, its preparation and pharmaceutical compositions containing it
EP0037082B1 (en) Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
CH667273A5 (de) Enolsilyletherverbindungen.
EP0026816B1 (en) Intermediates for the preparation of thienamycin and process for preparing intermediates
SE461734B (sv) Nya karbapenem-antibiotika samt foerfarande foer framstaellning daerav
HU192819B (en) Process for preparing antibacterial penemic derivatives
US4378315A (en) Process for the preparation of thienamycin and intermediates
US4739048A (en) Process for the preparation of thienamycin and intermediates
WO2004043961A1 (ja) 経口投与用カルバペネム化合物の製造方法
WO2004043973A1 (ja) 経口投与用カルバペネム化合物の新規合成中間体及びその製造方法
US4610820A (en) Process for the preparation of thienamycin and intermediates
EP0066301B1 (en) Intermediates for the preparation of thienamycin and process for preparing the same
FI78071C (fi) Mellanprodukt anvaendbar vid framstaellning av tienamycin.
US4400323A (en) 3-[1-Hydroxyethyl]-4-carboxymethyl-azetidin-2-one
US4736025A (en) Process for the preparation of thienamycin and intermediates
JPH0466872B2 (es)
IE48729B1 (en) Intermediates for the preparation of thienamycin and process for preparing same
EP0026817A1 (en) Preparation of azetidin-2-ones suitable for the synthesis of thienamycin and azetidin-2-ones useful in a synthesis of that kind
JP3543016B2 (ja) β−ラクタム系化合物の製法

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: MERCK & CO INC.